Timken India Ltd Q1 FY27 Results Analysis: Revenue Surges 14.87%, EBITDA Margin Expands 94 bps
Cofacto Research
Updated August 04, 2026
2 min read
Positive
Timken India Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 929.09 Cr (+14.87% YoY) and PAT growth of +10.46% YoY. Here's a quick read of what worked, what to watch, and what management said.
Quick Details| Results date | August 04, 2026 |
|---|
| Quarter | Q1 FY 2026-2027 |
|---|
| Revenue (Q1) | Rs. 929.09 Cr (+14.87% YoY) |
|---|
| PAT (Q1) | Rs. 115.13 Cr (+10.46% YoY) |
|---|
| EBITDA margin | 18.54% (+94 bps YoY) |
|---|
| EPS (Q1) | Rs. 15.31 (+10.46% YoY) |
|---|
| Market cap | Rs. 24,324.69 Cr |
|---|
| CMP | Rs. 3,231.90 |
|---|
Quarter Snapshot
Revenue grew 14.87% to a record Q1 high, EBITDA margins expanded 94 bps from price pass-through and operating leverage. Depreciation from Bharuch capex and higher tax rate capped reported PAT growth at 10.46%, but normalized PAT rose 16.45%. Zero-debt balance sheet and ongoing capacity expansions (Bharuch ramp-up, Jamshedpur rail) position the company for sustained growth.
Key Investment Insights
Key Positives
- Revenue grew 14.87% YoY to Rs.929.09 Cr, highest-ever first quarter.
- EBITDA grew 21.01% YoY to Rs.172.24 Cr, with margin expanding 94 bps to 18.54%.
- Normalized PAT grew 16.45% YoY to Rs.111.76 Cr.
- Net material cost as % of revenue improved 97 bps YoY to 60.09%, indicating successful price pass-through.
- Zero-debt balance sheet with cash equivalents of Rs.268.5 Cr provides ample liquidity.
- Consolidated PAT includes Rs.4.53 Cr from subsidiary, which is profitable.
Risk Factors
- Depreciation surged 50.62% YoY to Rs.31.33 Cr due to Bharuch plant capitalisation, limiting PAT growth to 10.46% vs EBITDA growth of 21.01%.
- Effective tax rate jumped 333 bps YoY to 23.42%, reducing net profit growth.
- Other expenses grew 15.47% YoY, in line with revenue, indicating ongoing ramp-up costs from Bharuch.
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.
Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings
Login Now